Radiopharm Theranostics
June 17, 2025
Company Presentation
Oncology
153A
Clinical Stage company focused on Radiopharmaceutical Therapies and Imaging
Company HQ City:
Carlton
Company HQ State:
Victoria
Company HQ Country:
Australia
Year Founded:
2021
Lead Product in Development:
RAD 101, RAD 204
CEO
CEO: Riccardo Canevari
Development Phase of Lead Product
Phase II
Number of Unlicensed Products Looking for Licensing
4
Exchange
NASDAQ
Ticker
RADX
When you expect your next catalyst update?
Clinical trial readouts
What is your next catalyst (value inflection) update?
Mid to end 2025
Website
www.radiopharmtheranostics.com
Primary Speaker
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}